“…This approach is particularly attractive if late-stage asymmetric transformation of the indole core into bioisosteric oxindoles could be achieved, which would facilitate the syntheses, discovery, and optimization of drug candidates . However, to our knowledge such a catalytic asymmetric transformation by either enzymatic or chemical protocol has never been reported, presumably owing to diverse indole oxidation pathways and difficulties in enantioselective manipulation of thermodynamically unstable oxidized intermediates (Scheme B). − Notably, even an effective catalytic nonasymmetric variant has remained undeveloped. , In this context, several heme enzymes catalyze oxidation of 3-substituted indole by O 2 or H 2 O 2 to generate a putative epoxyindole intermediate that undergoes 2,3-hydride migration to form monooxygenated oxindole with spontaneous keto–enol tautomerization in buffer . Moreover, considerable amounts of dioxygenated products, such as 2-ketoformanilide via C 2 –C 3 cleavage (Witkop oxidation) and 3-hydroxyl oxindole via overoxidation are also observed as major products. , …”